Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1660723

registered interest
date	14/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccine Damage Payment Scheme: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 September to Question 197988 on Vaccine Damage Payment Scheme: Coronavirus, how many and what proportion of the 221 claims rejected due to not meeting the 60% disability threshold would have met a disability threshold of (a) 50%, b) 40%, c) 30% and (d) 20%.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	199534
answer	answer is ministerial correction date of answer 19/09/2023 answer text <p>Of the 221 COVID-19 related claims rejected due to not meeting the 60% disability threshold, as of 1 September 2023, only nine, or 4%, potentially would have met a disability threshold of 50%; 34, or 15%, potentially would have met a disability threshold of 40%; 73, or 33%, potentially would have met a disability threshold of 30%; and 116, or 53%, potentially would have met a disability threshold of 20%. The data for lower thresholds is cumulative and includes claims that would meet a higher threshold.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 19/09/2023 14:34:27 answering member 4492 label Biography information for Maria Caulfield
tabling member	242 label Biography information for Sir Christopher Chope

1660727

registered interest
date	14/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Electronic Cigarettes: Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to monitor the potential health implications of increases in the number of young people using vapes.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	199542
answer	answer is ministerial correction date of answer 19/09/2023 answer text <p>We are concerned about the rise in the number of young people using vapes. There is well established concern about the addictive harms and risks from vaping, specifically associated with children and young people. Nicotine is highly addictive and there are unanswered questions on the effects of longer-term use.</p><p>That is why the Government ran a call for evidence on youth vaping which closed on 6 June 2023. This will identify opportunities to reduce the number of children accessing and using vaping products and explore where the government can go further to protect children from the harms of vaping.</p><p>We will respond to the call for evidence in due course.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 19/09/2023 12:21:27 answering member 4679 label Biography information for Neil O'Brien
tabling member	1409 label Biography information for Mr Gregory Campbell

1660728

registered interest
date	14/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the number and proportion of people with type 2 diabetes who will be affected by the shortage of GLP1-RA medications.
tabling member constituency	Slough
tabling member printed	Mr Tanmanjeet Singh Dhesi
uin	199596
answer	answer is ministerial correction date of answer 19/09/2023 answer text <p>The information requested is currently not held centrally. The Department is monitoring demand for GLP1-RA medication using prescriptions data from the NHS Business Services Authority.</p> answering member constituency Colchester answering member printed Will Quince question first answered 19/09/2023 15:57:51 answering member 4423 label Biography information for Will Quince
tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1660798

registered interest
date	14/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS Learning Support Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much his Department spent on Parental Support from the NHS Learning Support Fund in each of the last five years; and how many people have (a) made a claim and (b) been eligible for support under that scheme in each of the last five years.
tabling member constituency	Walthamstow
tabling member printed	Stella Creasy
uin	199572
answer	answer is ministerial correction date of answer 19/09/2023 answer text <p>The following table shows for the years 2018/19 to 2022/23 the number of students who received an element of funding from the NHS Learning Support Fund, together with the number of students who received available childcare component and its corresponding expenditure:</p><table><tbody><tr><td><p>Financial Year</p></td><td><p>2018/19</p></td><td><p>2019/20</p></td><td><p>2020/21</p></td><td><p>2021/22</p></td><td><p>2022/23</p></td></tr><tr><td><p>Students who Received an Element of Funding</p></td><td><p>14,067</p></td><td><p>26,382</p></td><td><p>110,923</p></td><td><p>130,213</p></td><td><p>133,658</p></td></tr><tr><td><p>Students in Receipt of Child Dependants Allowance (CDA) or Parental Support (PS)</p></td><td><p>8,014</p></td><td><p>14,013</p></td><td><p>36,192</p></td><td><p>34,034</p></td><td><p>35,649</p></td></tr><tr><td><p>CDA and PS Expenditure (£)</p></td><td><p>5,908,671</p></td><td><p>11,700,520</p></td><td><p>35,068,824</p></td><td><p>49,751,801</p></td><td><p>52,565,170</p></td></tr></tbody></table><p> </p><p>Source: NHS Business Services Authority</p> answering member constituency Colchester answering member printed Will Quince question first answered 19/09/2023 15:14:32 answering member 4423 label Biography information for Will Quince
tabling member	4088 label Biography information for Stella Creasy

1660799

registered interest
date	14/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Social Work: Training
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much his Department spent on the Childcare Allowance and Parents’ Learning Allowance of the Social Work Bursary in each of the last five years; and how many people have (a) made a claim and (b) been eligible for support under that scheme in each of the last five years.
tabling member constituency	Walthamstow
tabling member printed	Stella Creasy
uin	199573
answer	answer is ministerial correction date of answer 19/09/2023 answer text <p><strong>Suggested reply</strong></p><p>The following table shows the breakdown of funding offered to parents across the Social Work Bursary scheme:</p><table><tbody><tr><td><p>Financial Year</p></td><td><p>Number of students in receipt of Parent Learning Allowance</p></td><td><p>Parent Learning Allowance Expenditure (£)</p></td><td><p>Number of students in receipt of Childcare Allowance</p></td><td><p>Childcare Allowance Expenditure (£)</p></td></tr><tr><td><p>2018/19</p></td><td><p>1,239</p></td><td><p>1,236,341</p></td><td><p>567</p></td><td><p>2,114,319</p></td></tr><tr><td><p>2019/20</p></td><td><p>1,256*</p></td><td><p>1,211,047</p></td><td><p>630*</p></td><td><p>2,124,705</p></td></tr><tr><td><p>2020/21</p></td><td><p>1,175</p></td><td><p>1,183,842</p></td><td><p>573</p></td><td><p>2,252,088</p></td></tr><tr><td><p>2021/22</p></td><td><p>1,083</p></td><td><p>1,061,297</p></td><td><p>458</p></td><td><p>1,941,897</p></td></tr><tr><td><p>2022/23</p></td><td><p>958</p></td><td><p>911,748</p></td><td><p>389</p></td><td><p>1,484,316</p></td></tr></tbody></table><p>Source: NHS Business Services Authority (NHS BSA)</p><p>Note: NHS BSA cannot give a count of applications that were deemed ineligible for the parent learning allowance or childcare allowance, as they do not directly record this in their systems. The information for the 2019/20 financial year contains data from two different IT systems with no unique identifiers, so there is a possibility of duplication in the count of students funded.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 19/09/2023 19:09:55 answering member 4527 label Biography information for Helen Whately
tabling member	4088 label Biography information for Stella Creasy

1660807

registered interest
date	14/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to increase stocks of diabetes medication.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Paula Barker
uin	199678
answer	answer is ministerial correction date of answer 19/09/2023 answer text <p>We are aware of a supply issue with Ozempic. We have issued guidance in the form of Medicine Supply Notifications and, on 18 July 2023, issued a National Patient Safety Alert with advice for healthcare professionals on how to manage patients requiring this medicine. Our guidance is clear that glucagon-like peptide 1 receptor agonist medicines, such as Ozempic, that are solely licensed to treat Type 2 diabetes should only be used for that purpose and should not be routinely prescribed for weight loss.</p><p>The General Pharmaceutical Council, General Medical Council, Health and Care Professions Council, Nursing and Midwifery Council and Pharmaceutical Society of Northern Ireland have also issued a joint statement stressing the importance of health and care professionals meeting regulatory standards in relation to these medicines. We have also added some of these products to the list of medicines that cannot be exported from, or hoarded in, the United Kingdom.</p><p>We are continuing to work closely with manufacturers and others working in the supply chain to help ensure the continued supply of these medicines for patients in the UK, for example by asking suppliers to expedite deliveries. We have provided advice for healthcare professionals on how to manage patients requiring this medicine whilst there are shortages and are keeping this under review as the situation evolves. If any patient is concerned about their treatment, they should discuss this with their clinician at the earliest opportunity.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 199679 question first answered 19/09/2023 09:35:57 answering member 4423 label Biography information for Will Quince
tabling member	4828 label Biography information for Paula Barker

1660809

registered interest
date	14/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to restrict off-label prescription of diabetes medication.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Paula Barker
uin	199679
answer	answer is ministerial correction date of answer 19/09/2023 answer text <p>We are aware of a supply issue with Ozempic. We have issued guidance in the form of Medicine Supply Notifications and, on 18 July 2023, issued a National Patient Safety Alert with advice for healthcare professionals on how to manage patients requiring this medicine. Our guidance is clear that glucagon-like peptide 1 receptor agonist medicines, such as Ozempic, that are solely licensed to treat Type 2 diabetes should only be used for that purpose and should not be routinely prescribed for weight loss.</p><p>The General Pharmaceutical Council, General Medical Council, Health and Care Professions Council, Nursing and Midwifery Council and Pharmaceutical Society of Northern Ireland have also issued a joint statement stressing the importance of health and care professionals meeting regulatory standards in relation to these medicines. We have also added some of these products to the list of medicines that cannot be exported from, or hoarded in, the United Kingdom.</p><p>We are continuing to work closely with manufacturers and others working in the supply chain to help ensure the continued supply of these medicines for patients in the UK, for example by asking suppliers to expedite deliveries. We have provided advice for healthcare professionals on how to manage patients requiring this medicine whilst there are shortages and are keeping this under review as the situation evolves. If any patient is concerned about their treatment, they should discuss this with their clinician at the earliest opportunity.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 199678 question first answered 19/09/2023 09:35:57 answering member 4423 label Biography information for Will Quince
tabling member	4828 label Biography information for Paula Barker

1660814

registered interest
date	14/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccine Damage Payment Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many claims under the Vaccine Damage Payments Scheme have been received between October 2021 and September 2023; how many of these claims relate to vaccines for (a) Covid-19 and (b) other illnesses; and how many claims are still awaiting a final decision per vaccine.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	199535
answer	answer is ministerial correction date of answer 19/09/2023 answer text <p>From 1 October 2021 to 1 September 2023, the NHS Business Services Authority has received 6,809 claims relating to COVID-19 vaccinations, and 251 claims relating to vaccines for other illnesses.</p><p>Of these claims, 3,933 are currently awaiting a final decision; of which, 3,796 are related to vaccines for COVID-19 and 137 are related to vaccines for other illnesses. These 137 are broken down per vaccine as follows:</p><p>- 35 are adult flu</p><p>- 33 are unidentified/unclear due to multiple types of vaccinations</p><p>- 17 are diphtheria, tetanus, pertussis, polio and haemophilus influenzae type b (DTaP/IPV/Hib)</p><p>- 15 are measles, mumps and rubella (MMR)</p><p>- 9 are human papillomavirus (HPV)</p><p> </p><p>The following vaccines have received fewer than five claims and the exact amount cannot be disclosed as this information may make individuals personally identifiable in the public domain:</p><p>- Influenza</p><p>- Swine flu (Pandemic influenza A (H1N1) 2009)</p><p>- Polio (Poliomyelitis - orally administered)</p><p>- Unidentified/unclear</p><p>- Haemophilus influenzae type b, meningococcal group C (Hib/Men C)</p><p>- Haemophilus influenzae type b (Hib)</p><p>- Meningococcal group C (Men C, Men ACWY)</p><p>- Pneumococcal (PCV)</p><p>- Tuberculosis (TB)</p><p>- Tetanus</p><p>- Mumps</p><p>- Meningococcal group B (Men B)</p><p>- Diphtheria, tetanus, pertussis and polio (DTaP/IPV)</p><p>- Rubella (German measles)</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 19/09/2023 14:36:20 answering member 4492 label Biography information for Maria Caulfield
tabling member	242 label Biography information for Sir Christopher Chope

1660874

registered interest
date	14/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	UK Health Security Agency: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the R&D budget is of the UK Health Security Agency Vaccine Development and Evaluation Centre.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	199593
answer	answer is ministerial correction date of answer 19/09/2023 answer text <p>The information is not held in the format requested as the research &amp; development budget is not separated from the wider budget of the Vaccine Development and Evaluation Centre.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 19/09/2023 16:46:23 answering member 4492 label Biography information for Maria Caulfield
tabling member	4124 label Biography information for Chi Onwurah

1660876

registered interest
date	14/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an estimate of the potential cost of providing (a) anti-inflammatory and (b) immunomodulatory treatment to young people where the potential merits of doing so outweigh the potential harms.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	199656
answer	answer is ministerial correction date of answer 19/09/2023 answer text <p>We have no plans to make such an estimate.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 19/09/2023 14:37:19 answering member 4492 label Biography information for Maria Caulfield
tabling member	4244 label Biography information for Jonathan Ashworth